These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 23107776)

  • 1. Protein damage, repair and proteolysis.
    Chondrogianni N; Petropoulos I; Grimm S; Georgila K; Catalgol B; Friguet B; Grune T; Gonos ES
    Mol Aspects Med; 2014 Feb; 35():1-71. PubMed ID: 23107776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein oxidation in aging and the removal of oxidized proteins.
    Höhn A; König J; Grune T
    J Proteomics; 2013 Oct; 92():132-59. PubMed ID: 23333925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and protein aggregation during biological aging.
    Squier TC
    Exp Gerontol; 2001 Sep; 36(9):1539-50. PubMed ID: 11525876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removing protein aggregates: the role of proteolysis in neurodegeneration.
    Nijholt DA; De Kimpe L; Elfrink HL; Hoozemans JJ; Scheper W
    Curr Med Chem; 2011; 18(16):2459-76. PubMed ID: 21568912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
    Ciechanover A
    Medicina (B Aires); 2010; 70(2):105-19. PubMed ID: 20447892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
    Ciechanover A
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):341-355. PubMed ID: 29156207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. It's all about talking: two-way communication between proteasomal and lysosomal degradation pathways via ubiquitin.
    Liebl MP; Hoppe T
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C166-78. PubMed ID: 27225656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild type and mutant amyloid precursor proteins influence downstream effects of proteasome and autophagy inhibition.
    Cecarini V; Bonfili L; Cuccioloni M; Mozzicafreddo M; Rossi G; Keller JN; Angeletti M; Eleuteri AM
    Biochim Biophys Acta; 2014 Feb; 1842(2):127-34. PubMed ID: 24215712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of protein clearance mechanisms in organismal ageing and age-related diseases.
    Vilchez D; Saez I; Dillin A
    Nat Commun; 2014 Dec; 5():5659. PubMed ID: 25482515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein clearance strategies for disease intervention.
    Hommen F; Bilican S; Vilchez D
    J Neural Transm (Vienna); 2022 Feb; 129(2):141-172. PubMed ID: 34689261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbation of redox balance after thioredoxin reductase deficiency interrupts autophagy-lysosomal degradation pathway and enhances cell death in nutritionally stressed SH-SY5Y cells.
    Nagakannan P; Iqbal MA; Yeung A; Thliveris JA; Rastegar M; Ghavami S; Eftekharpour E
    Free Radic Biol Med; 2016 Dec; 101():53-70. PubMed ID: 27693380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation and ubiquitination in neurodegeneration.
    Riederer BM; Leuba G; Elhajj Z
    Exp Biol Med (Maywood); 2013 May; 238(5):519-24. PubMed ID: 23856903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders.
    Kumar P; Pradhan K; Karunya R; Ambasta RK; Querfurth HW
    J Neurochem; 2012 Feb; 120(3):350-70. PubMed ID: 22098618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome: a Nanomachinery of Creative Destruction.
    Kudriaeva AA; Belogurov AA
    Biochemistry (Mosc); 2019 Jan; 84(Suppl 1):S159-S192. PubMed ID: 31213201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. We Are What We Eat: Ubiquitin-Proteasome System (UPS) Modulation Through Dietary Products.
    Panagiotidou E; Chondrogianni N
    Adv Exp Med Biol; 2020; 1233():329-348. PubMed ID: 32274765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of the protein degradation pathway by the ubiquitin family: its implication in neurodegenerative diseases].
    Chiba T; Tanaka K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):976-8. PubMed ID: 16447778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.